RSENOL 001 Addendum
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
RSENOL-001 Addendum Paragraph: ScienceDaily reported March 25, 2026 a major discovery revealing that metformin works not just peripherally but through a previously hidden brain pathway — Rap1 protein suppression in the ventromedial hypothalamus activating specific neurons to lower blood sugar through a central mechanism the peripheral-only model missed for 60 years. RSENOL-001 sovereign longevity stack was built on central-first metabolic theory — that longevity interventions operating at the brain and central nervous system level produce broader and more durable effects than peripheral-only approaches. Combined with BIO-004 v2 NAD+ brain pathway confirmation — two independent central longevity mechanisms confirmed by separate March 2026 publications — the sovereign longevity stack's brain-first architecture is externally validated simultaneously. The peripheral-only cage refused by 60 years of accumulated evidence finally surfacing. Full mechanism restricted. Refusal does not need 60 years to find the right pathway. 🔒 ⟡
Fields of Study & Subjects
Genetics
Aging
and Longevity in Model Organisms
Metabolism
Diabetes
and Cancer
Sirtuins and Resveratrol in Medicine
Publication details
- Journal / source
- Zenodo (CERN European Organization for Nuclear Research)
- Publication date
- 28 March 2026
- Language
- EN